ES2061380A1 - Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores. - Google Patents

Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.

Info

Publication number
ES2061380A1
ES2061380A1 ES09202360A ES9202360A ES2061380A1 ES 2061380 A1 ES2061380 A1 ES 2061380A1 ES 09202360 A ES09202360 A ES 09202360A ES 9202360 A ES9202360 A ES 9202360A ES 2061380 A1 ES2061380 A1 ES 2061380A1
Authority
ES
Spain
Prior art keywords
fibroblast growth
neuroprotective
growth factors
ischaemia
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09202360A
Other languages
English (en)
Other versions
ES2061380B1 (es
Inventor
Gallego Guillermo Gimenez
Sanchez Pedro Cuevas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUILLERMO GIMENEZ GALLEGO (TITULAR AL 50%)
Original Assignee
Boehringer Ingelheim Espana SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Espana SA filed Critical Boehringer Ingelheim Espana SA
Priority to ES09202360A priority Critical patent/ES2061380B1/es
Priority to JP6512718A priority patent/JPH07504205A/ja
Priority to PCT/EP1993/003234 priority patent/WO1994012201A1/en
Priority to EP94901818A priority patent/EP0624094A1/en
Priority to CA002127537A priority patent/CA2127537A1/en
Publication of ES2061380A1 publication Critical patent/ES2061380A1/es
Application granted granted Critical
Publication of ES2061380B1 publication Critical patent/ES2061380B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EMPLEO DEL FACTOR DE CRECIMIENTO FIBROBLASTICO Y SUS DERIVADOS COMO NEUROPROTECTORES Y NEUROMODULADORES FRENTE AL DAÑO PRODUCIDO POR LA ISQUEMIA Y LA REPERFUSION CEREBRAL, ASI COMO FRENTE A LA ACTIVIDAD MOTORA Y A TODOS LOS COMPUESTOS RELACIONADOS CON LA MISMA, EN AQUELLAS SITUACIONES CLINICAS QUE REQUIERAN UNA PROTECCION NEURONAL TRAS LA ISQUEMIA CEREBRAL O CAROTIDEA. IGUALMENTE, SE JUSTIFICA EL USO FARMACOLOGICO DEL FACTOR DE CRECIMIENTO DE LOS FIBROBLASTOS ACIDOS Y BASICOS, Y DE TODOS LOS COMPUESTOS RELACIONADOS CON LOS MISMOS, EN LAS SITUACIONES CLINICAS QUE REQUIERAN UNA DISMINUCION DE LA AGITACION Y DE LA AGRESIVIDAD.
ES09202360A 1992-11-23 1992-11-23 Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores. Expired - Lifetime ES2061380B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES09202360A ES2061380B1 (es) 1992-11-23 1992-11-23 Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.
JP6512718A JPH07504205A (ja) 1992-11-23 1993-11-19 神経保護及び神経調節の薬剤としての繊維芽細胞増殖因子の使用
PCT/EP1993/003234 WO1994012201A1 (en) 1992-11-23 1993-11-19 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents
EP94901818A EP0624094A1 (en) 1992-11-23 1993-11-19 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents
CA002127537A CA2127537A1 (en) 1992-11-23 1993-11-19 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09202360A ES2061380B1 (es) 1992-11-23 1992-11-23 Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.

Publications (2)

Publication Number Publication Date
ES2061380A1 true ES2061380A1 (es) 1994-12-01
ES2061380B1 ES2061380B1 (es) 1995-07-01

Family

ID=8278876

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09202360A Expired - Lifetime ES2061380B1 (es) 1992-11-23 1992-11-23 Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.

Country Status (5)

Country Link
EP (1) EP0624094A1 (es)
JP (1) JPH07504205A (es)
CA (1) CA2127537A1 (es)
ES (1) ES2061380B1 (es)
WO (1) WO1994012201A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831117A (en) 1995-01-20 1998-11-03 G. D. Searle & Co. Method of preparing retroviral protease inhibitor intermediates
EP0741143B1 (en) * 1995-04-25 2005-07-06 Ajinomoto Co., Inc. Fibroblast growth factor fragments
EP0894004B2 (en) * 1996-03-22 2007-02-21 Curis, Inc. Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma
JP2002512627A (ja) * 1997-06-11 2002-04-23 アコーダ セラピーティックス Ｃｎｓ神経再生組成物及びその使用方法
AU8855798A (en) * 1997-07-03 1999-01-25 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Novel composition for treating, preventing and/or delaying ischemic cell death
JP3507884B2 (ja) * 2000-03-07 2004-03-15 新潟大学長 遺伝子発現を指標とする統合失調症の客観的診断法
DK1766077T3 (da) 2004-06-21 2012-07-16 Univ Leland Stanford Junior Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse
AU2006315562C1 (en) 2005-11-12 2013-10-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating depression using NCAM peptide mimetics

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357240A2 (en) * 1988-08-03 1990-03-07 Ethicon, Inc. EGF for preventing tissue damage after ischemia
EP0388226A2 (en) * 1989-03-16 1990-09-19 Ajinomoto Co., Inc. Means for the treatment of senile dementia, memory disorders and related conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008828A1 (en) * 1991-11-08 1993-05-13 Syntex-Synergen Neuroscience Joint Venture Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357240A2 (en) * 1988-08-03 1990-03-07 Ethicon, Inc. EGF for preventing tissue damage after ischemia
EP0388226A2 (en) * 1989-03-16 1990-09-19 Ajinomoto Co., Inc. Means for the treatment of senile dementia, memory disorders and related conditions

Also Published As

Publication number Publication date
JPH07504205A (ja) 1995-05-11
CA2127537A1 (en) 1994-06-09
EP0624094A1 (en) 1994-11-17
ES2061380B1 (es) 1995-07-01
WO1994012201A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
USD291680S (en) Automobile valance panel
IL74860A0 (en) Motor vehicle accessory particularly useful for protecting the vehicle against theft
USD367443S (en) Truck cab body
ES2061380A1 (es) Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.
IT8422619U1 (it) Brandina o lettino a struttura deformabile per cabine di veicoli industriali e simili, particolarmente adatta per ridurre i danni al conducente in caso di incidenti stradali.
CA2155329A1 (en) Acylfulvene analogues as antitumor agents
SG49654A1 (en) The use of hyaluronic acid to repair ischemia reperfusion damage
GR3022801T3 (en) Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity.
AU3839393A (en) Improvements in or relating to organic compounds
DE10296213D2 (de) Schutztür für Fahrerkabinen, insbesondere von Nutzfahrzeugen
DE69302571D1 (de) Frontkraftheber für traktor oder dergleichen
GB1133674A (en) Improvements relating to motor vehicles
USD346076S (en) Bunk bed
ES2011264B3 (es) Cuerpo de vehiculo provisto de guardabarros adaptado a proteger las ruedas.
DK0621926T3 (da) Styreliste til en beskyttelseshætte til træfræsemaskiner
GB961121A (en) Improvements relating to motor vehicles
USD299775S (en) Lifting bed accessory for the repair of vehicle bodies
USD291681S (en) Automobile valance panel
USD291679S (en) Automobile rear bumper
USD295165S (en) Automobile front bumper
USD295166S (en) Automobile front bumper
GB2269147B (en) Vehicle body panel protector
PL285647A1 (en) Driving wheel with protection against car theft
IT217193Z2 (it) Pedana per l accesso alla cabina diguida di un veicolo industriale
MX9503283A (es) Montaje de protector contra choques de borde y rueda para maleta rodante.

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: GUILLERMO GIMENEZ GALLEGO (TITULAR AL 50%)